In order to explore whether SGC707 could suppress PRMT3‐mediated HCC growth in vivo, xenograft nude mice were intraperitoneally administrated with SGC707 or vehicle every 2 days with the dose of 30 mg/kg from the day after subcutaneous injection onward. Here, PRMT3 is linked to hepatocellular carcinoma.